0001214659-22-000267.txt : 20220104 0001214659-22-000267.hdr.sgml : 20220104 20220104182039 ACCESSION NUMBER: 0001214659-22-000267 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chappell Dale CENTRAL INDEX KEY: 0001379459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 22508254 MAIL ADDRESS: STREET 1: C/O OPUS EQUUM INC. STREET 2: PO BOX 788 CITY: DOLORES STATE: CO ZIP: 81323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HUMANIGEN, INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 533 AIRPORT BLVD. STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20040609 4 1 marketforms-54937.xml PRIMARY DOCUMENT X0306 4 2021-12-31 0001293310 HUMANIGEN, INC HGEN 0001379459 Chappell Dale C/O OPUS EQUUM INC P.O. BOX 788 DOLORES CO 81323 true true true false Chief Scientific Officer Stock Option (Right to Buy) 3.72 2021-12-31 4 A false 44600 0 A 2022-03-31 2031-12-30 Common Stock 44600 44600 D The option vests in 12 ratable quarterly installments commencing March 31, 2022. /s/ Dale Chappell 2022-01-04